Conditioned Place Preference Reinstatement
Overview
CPP reinstatement models relapse by testing whether a drug priming injection, stress exposure, or conditioned cue can restore an extinguished place preference. After CPP is established and subsequently extinguished, the subject receives a triggering stimulus (typically a sub-threshold drug dose, footshock stress, or drug-associated cue) immediately before a free-access test session. Reinstatement is mediated by distinct but overlapping circuits: drug priming activates VTA-NAc dopamine projections, stress reinstates via corticotropin-releasing factor in the bed nucleus of the stria terminalis, and cue reinstatement involves basolateral amygdala-to-prefrontal pathways.
The reinstatement score is the difference between the reinstated CPP score and the final extinction CPP score, with a positive value indicating restoration of preference. The magnitude of reinstatement relative to the original CPP score indicates the proportion of the drug memory that was reactivated. Transition counts during reinstatement help differentiate approach-motivated reinstatement from anxiety-driven side avoidance. Locomotor activity confirms that reinstatement reflects specific motivational changes rather than generalized behavioral activation from the priming stimulus.
ConductMaze integrates the full CPP acquisition-extinction-reinstatement workflow in a single protocol timeline, maintaining continuous subject tracking across phases. The system automatically computes reinstatement indices referenced to both extinction baseline and original CPP magnitude. The platform supports multiple reinstatement trigger types with configurable pre-session intervals for drug pharmacokinetics. Time-bin analysis within the reinstatement session reveals whether preference is immediate or emerges over time.
Trial Flow
Extinction Verification
Confirm CPP has been extinguished by verifying preference score is at criterion.
Reinstatement Trigger
Administer priming stimulus (drug injection, stress, or cue presentation).
Absorption Interval
Wait for drug onset or stress response before placing subject in apparatus.
Reinstatement Test
Subject explores all compartments with free access; record dwell times.
Reinstatement Assessment
Compare reinstatement CPP score to extinction baseline and original CPP magnitude.
Data Export
Export reinstatement indices, time-bin preference data, and full longitudinal CPP trajectory.
Protocol Complete
Clean apparatus; archive complete acquisition-extinction-reinstatement dataset.
Parameters
| Parameter | Type | Default | Description |
|---|---|---|---|
| Reinstatement Test Duration | duration | 20 min | Duration of the post-priming free-access reinstatement test. |
| Priming Stimulus Type | enum | drug | Type of reinstatement trigger: drug priming, stress, or conditioned cue. |
| Drug-Test Interval | duration | 15 min | Delay between drug priming injection and reinstatement test start. |
| Stress Duration | duration | 10 min | Duration of stress exposure (footshock or restraint) if stress reinstatement. |
| Priming Dose Fraction | float | 0.25 | Fraction of original conditioning dose used for drug priming (e.g., 0.25 = quarter dose). |
| Time Bin Size | duration | 5 min | Duration of time bins for within-session preference analysis. |
| Door Open Delay | seconds | 5 | Delay after subject placement before doors open. |
Metrics
| Metric | Unit | Description |
|---|---|---|
| Reinstatement Score | s | Reinstatement CPP score minus extinction baseline CPP score. |
| Reinstatement CPP Score | s | Preference for the drug-paired side during the reinstatement test. |
| Reinstatement Ratio | ratio | Reinstatement score divided by original CPP score, indicating proportion of memory reactivated. |
| Drug Side Time | s | Absolute time in drug-paired compartment during reinstatement. |
| Compartment Transitions | count | Number of between-compartment crossings during reinstatement. |
| Distance Traveled | cm | Total locomotion during the reinstatement session. |
Sample Data
| Subject | Group | Extinction CPP (s) | Reinstatement CPP (s) | Reinstatement Score (s) | Transitions |
|---|
Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.
Applications
- 1Relapse Prevention Pharmacology — Screen anti-relapse compounds by measuring their ability to block drug-primed reinstatement of CPP.
- 2Stress-Induced Relapse — Model stress-triggered drug seeking using footshock or restraint stress as the reinstatement stimulus.
- 3Memory Reconsolidation — Test whether post-reactivation anisomycin or propranolol disrupts reconsolidation and prevents subsequent reinstatement.
- 4Circuit-Specific Relapse Mechanisms — Use pathway-specific chemogenetics to identify which projections are necessary for cue versus drug versus stress reinstatement.
Related Protocols
Compatible Products
Ready to Automate Your Behavioral Protocols?
Contact us for a demo and pricing information.